Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) to Fund, Support First-Ever Psychedelic Treatment Clinic at Manhattan Hospital
Company receives grant to fund clinic for marginalized, underserved NYC communitiesNew clinic will offer psychedelic treatment with no out-of-pocket cost for individuals unable to afford the serviceProgram’s clinicians will receive specialized training Cybin (NEO: CYBN) (NYSE American: CYBN), a biopharmaceutical company focused on progressing psychedelics to therapeutics, is marking key milestones in its mission to revolutionize mental healthcare. The company recently received a grant for the…